Matches in Wikidata for { <http://www.wikidata.org/entity/Q91719154> ?p ?o ?g. }
Showing items 1 to 61 of
61
with 100 items per page.
- Q91719154 description "artículu científicu espublizáu n'avientu de 2019" @default.
- Q91719154 description "scientific article published on 01 December 2019" @default.
- Q91719154 description "wetenschappelijk artikel" @default.
- Q91719154 description "наукова стаття, опублікована 1 грудня 2019" @default.
- Q91719154 name "A multicenter randomized phase III study for newly diagnosed maximally resected glioblastoma comparing carmustine wafer implantation followed by chemoradiotherapy with temozolomide with chemoradiotherapy alone; Japan Clinical Oncology Group Study JC" @default.
- Q91719154 name "A multicenter randomized phase III study for newly diagnosed maximally resected glioblastoma comparing carmustine wafer implantation followed by chemoradiotherapy with temozolomide with chemoradiotherapy alone; Japan Clinical Oncology Group Study JC" @default.
- Q91719154 type Item @default.
- Q91719154 label "A multicenter randomized phase III study for newly diagnosed maximally resected glioblastoma comparing carmustine wafer implantation followed by chemoradiotherapy with temozolomide with chemoradiotherapy alone; Japan Clinical Oncology Group Study JC" @default.
- Q91719154 label "A multicenter randomized phase III study for newly diagnosed maximally resected glioblastoma comparing carmustine wafer implantation followed by chemoradiotherapy with temozolomide with chemoradiotherapy alone; Japan Clinical Oncology Group Study JC" @default.
- Q91719154 prefLabel "A multicenter randomized phase III study for newly diagnosed maximally resected glioblastoma comparing carmustine wafer implantation followed by chemoradiotherapy with temozolomide with chemoradiotherapy alone; Japan Clinical Oncology Group Study JC" @default.
- Q91719154 prefLabel "A multicenter randomized phase III study for newly diagnosed maximally resected glioblastoma comparing carmustine wafer implantation followed by chemoradiotherapy with temozolomide with chemoradiotherapy alone; Japan Clinical Oncology Group Study JC" @default.
- Q91719154 P1433 Q91719154-0A0FE83B-6FCA-43B4-A59C-B79154289655 @default.
- Q91719154 P1476 Q91719154-60FB5A4E-71D7-402B-95B8-9733DFF47995 @default.
- Q91719154 P2093 Q91719154-16AE6417-6F0C-4DB7-B5D2-8C7037BFA966 @default.
- Q91719154 P2093 Q91719154-5D804CE9-9620-450B-8331-8786AE2746EF @default.
- Q91719154 P2093 Q91719154-884FC203-5904-4519-9407-3F37F3B5E806 @default.
- Q91719154 P2093 Q91719154-96F32C89-D499-47F9-82EC-523806C1615C @default.
- Q91719154 P2093 Q91719154-BEBB5014-7B2A-4B16-881E-F3597EA5980D @default.
- Q91719154 P2093 Q91719154-C0DE1F61-DC28-4FC5-8331-05D8852350C9 @default.
- Q91719154 P2093 Q91719154-C1585E8B-F8F1-4E4C-81DD-00EB65B911FF @default.
- Q91719154 P2093 Q91719154-C2B9B6D8-EE20-49C2-B36A-48DF7EB1710C @default.
- Q91719154 P2093 Q91719154-E11F9AE0-5AFD-4299-AEC3-126FFC6E8515 @default.
- Q91719154 P2093 Q91719154-E713945E-DDE4-44F2-A576-40C557CE17D3 @default.
- Q91719154 P2093 Q91719154-F162CB86-3B6B-458E-8DA7-BBC20EDF66CC @default.
- Q91719154 P304 Q91719154-D62DF145-F724-4191-849D-7FAD0A90656D @default.
- Q91719154 P31 Q91719154-D417D5ED-8E93-4EC8-BBE0-BEEC09017C71 @default.
- Q91719154 P356 Q91719154-1A9E2468-F0F9-4C6B-B29D-E0B6CEA813B6 @default.
- Q91719154 P433 Q91719154-45D6C82A-6410-44AE-9D00-19F27491BA4F @default.
- Q91719154 P478 Q91719154-06D6EA06-6888-483C-9482-FE63B9805024 @default.
- Q91719154 P50 Q91719154-94DA18FE-C9B9-4C28-BD24-0DFA36301B2C @default.
- Q91719154 P577 Q91719154-27F18D38-BA8D-415E-9E88-1B6A79F6F9D8 @default.
- Q91719154 P698 Q91719154-9130377B-88EE-4BC8-8716-5C0430FD8EED @default.
- Q91719154 P921 Q91719154-7C53C596-7B5E-42A7-9C77-48ABEC0B2AA1 @default.
- Q91719154 P921 Q91719154-AF20C575-82F0-4A2D-AF2E-CF5DD5C9EECB @default.
- Q91719154 P921 Q91719154-E67ADDCD-54A7-41B2-AF1D-6FCFE2D14D41 @default.
- Q91719154 P356 HYZ169 @default.
- Q91719154 P698 31804699 @default.
- Q91719154 P1433 Q2231629 @default.
- Q91719154 P1476 "A multicenter randomized phase III study for newly diagnosed maximally resected glioblastoma comparing carmustine wafer implantation followed by chemoradiotherapy with temozolomide with chemoradiotherapy alone; Japan Clinical Oncology Group Study JCOG1703 (MACS study)" @default.
- Q91719154 P2093 "Hiroshi Katayama" @default.
- Q91719154 P2093 "Junki Mizusawa" @default.
- Q91719154 P2093 "Koichi Ichimura" @default.
- Q91719154 P2093 "Manabu Kinoshita" @default.
- Q91719154 P2093 "Minako Sumi" @default.
- Q91719154 P2093 "Ryo Nishikawa" @default.
- Q91719154 P2093 "Ryuta Saito" @default.
- Q91719154 P2093 "Takashi Komori" @default.
- Q91719154 P2093 "Tomohiro Kadota" @default.
- Q91719154 P2093 "Toshihiro Kumabe" @default.
- Q91719154 P2093 "Yoshitaka Narita" @default.
- Q91719154 P304 "1172-1175" @default.
- Q91719154 P31 Q13442814 @default.
- Q91719154 P356 "10.1093/JJCO/HYZ169" @default.
- Q91719154 P433 "12" @default.
- Q91719154 P478 "49" @default.
- Q91719154 P50 Q73264505 @default.
- Q91719154 P577 "2019-12-01T00:00:00Z" @default.
- Q91719154 P698 "31804699" @default.
- Q91719154 P921 Q12322152 @default.
- Q91719154 P921 Q282142 @default.
- Q91719154 P921 Q425088 @default.